Oral gel capsule formulation of 1,2,4-benzotriazine oxides
A Standard patent application filed on 21 August 1996 credited to Blundell, Ross
;
Brown, Stephen
Details
Application number :
67800
Application type :
Standard
Application status :
CEASED
Under opposition :
No
Proceeding type :
Invention title :
Oral gel capsule formulation of 1,2,4-benzotriazine oxides
Inventor :
Blundell, Ross
;
Brown, Stephen
Agent name :
PHILLIPS ORMONDE FITZPATRICK
Address for service :
367 Collins Street MELBOURNE VIC 3000
Filing date :
21 August 1996
Associated companies :
Applicant name :
Sanofi-Aventis U.S. LLC
Applicant address :
55 Corporate Drive, Bridgewater, New Jersey 08807 United States Of America
Old name :
Sanofi Pharmaceuticals, Inc.
;
Sanofi Winthrop, Inc.
;
Sanofi-Synthelabo Inc.